Before the U.S. Preventive Services Task Force Panel’s 2012 recommendation against broad PSA screening, the blood test was commonly offered to men age 50 and over (45 if you had known risk factors). The Panel’s directive started a push in the opposite direction, encouraging doctors to discuss with each patient the merits and downsides of keep reading
I can’t begin to count the number of times patients have asked me questions like these: “Why isn’t focal laser ablation covered by Medicare or insurance?” “My urologist said he won’t do my follow-up if I have focal laser ablation. Do you know a laser-friendly urologist in my area who will work with me?” “How keep reading
On November 18, 2015 the New York Times carried an article titled “Early Prostate Cancer Cases Fall Along With Screening.” Ever since the U.S. Preventive Services Task Force recommended against broad PSA screening on the grounds that it leads to overdetection and overtreatment, two opposing positions have been created. One position favors the recommendation on keep reading